Jyske Realkredit A/S
17.3.2026 08:54:59 CET | Globenewswire | Press release
Minutes from the Annual General Meeting of Jyske Realkredit A/S
Minutes from the Annual General Meeting of Jyske Realkredit A/S
To Nasdaq Copenhagen A/S 17 March 2026
Announcement no. 22/2026
Minutes from the Annual General Meeting of Jyske Realkredit A/S
The Annual General Meeting of Jyske Realkredit A/S was held on 16 March 2026. The directors’ re-port was taken as read, the annual report for the year ended 31 December 2025 was adopted, and a resolution for the distribution of the net profit for the year was passed.
The General Meeting unanimously re-elected Lars Stensgaard Mørch, Lars Waalen Sandberg, Peter Schleidt and Morten Lykke to the Supervisory Board.
EY was reelected as auditors of the company.
At the subsequent meeting of the Supervisory Board, Lars Stensgaard Mørch was appointed as Chairman and Lars Waalen Sandberg as Deputy Chairman.
Yours sincerely,
Jyske Realkredit
Please observe that the Danish version of this announcement prevails.
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Schneider Electric19.4.2026 09:00:00 CEST | Press release
Challenge accepted: Schneider Electric helps industry turn toughest problems into competitive advantage
Chery Group18.4.2026 15:54:00 CEST | Press release
iCAUR V27 Secures CATARC L3 Off-Road Certification, Solidifying Its New Energy Off-Road Capability with Robust Technology
Sanofi Winthrop Industrie18.4.2026 12:00:00 CEST | Press release
Press Release: ESCMID: Sanofi's Nuvaxovid COVID-19 vaccine showed better tolerability than mNEXSPIKE in head-to-head study
Organizing Committee of the 2026 Fujian Provincial Conference on the Development of Cultural and Tourism Economy18.4.2026 06:50:27 CEST | Press release
2026 Fujian Provincial Conference on Development of Cultural, Tourism Economy opens on Apr. 17 in Zhangzhou, SE China's Fujian
Evaxion17.4.2026 21:10:00 CEST | Press release
Evaxion’s AI-Immunology™ platform demonstrates 86% vaccine target precision in phase 2 personalized cancer vaccine trial
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom